Stoxx Europe 50 846421 / EU0009658160
4’849.91
Pkt
-32.03
Pkt
-0.66
%
17:50:00
Anzeige
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | Trading-Depot |
| Marktkapitalisierung | |||||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu Stoxx Europe 50-Werten
| 31.01.25 | Shell Buy | UBS AG | |
| 31.01.25 | BBVA Buy | Deutsche Bank AG | |
| 31.01.25 | Intesa Sanpaolo Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | Novartis Outperform | Bernstein Research | |
| 31.01.25 | Prosus Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | Rheinmetall Buy | Deutsche Bank AG | |
| 31.01.25 | Sanofi Hold | Deutsche Bank AG | |
| 31.01.25 | Novartis Hold | Jefferies & Company Inc. | |
| 31.01.25 | SAP Buy | Goldman Sachs Group Inc. | |
| 31.01.25 | ASML NV Outperform | Bernstein Research | |
| 31.01.25 | ABB Neutral | UBS AG | |
| 30.01.25 | Shell Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | Shell Buy | Jefferies & Company Inc. | |
| 30.01.25 | Shell Outperform | RBC Capital Markets | |
| 30.01.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | ASML NV Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.01.25 | ASML NV Buy | Deutsche Bank AG | |
| 30.01.25 | Diageo Neutral | JP Morgan Chase & Co. | |
| 30.01.25 | Sanofi Outperform | Bernstein Research | |
| 30.01.25 | Roche Outperform | Bernstein Research | |
| 30.01.25 | ABB Underperform | Bernstein Research | |
| 30.01.25 | LVMH Moet Hennessy Louis Vuitton Outperform | Bernstein Research | |
| 30.01.25 | Schneider Electric Outperform | Bernstein Research | |
| 30.01.25 | ASML NV Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | Deutsche Telekom Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | EssilorLuxottica Neutral | UBS AG | |
| 30.01.25 | GSK Neutral | UBS AG | |
| 30.01.25 | SAP Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | AstraZeneca Neutral | UBS AG | |
| 30.01.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 30.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | ABB Neutral | UBS AG | |
| 30.01.25 | Roche Neutral | UBS AG | |
| 30.01.25 | Sanofi Buy | UBS AG | |
| 30.01.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | Shell Outperform | RBC Capital Markets | |
| 30.01.25 | ASML NV Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | ASML NV Neutral | UBS AG | |
| 30.01.25 | ABB Neutral | Goldman Sachs Group Inc. |